---
document_datetime: 2023-09-21 20:48:53
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/docetaxel-teva-epar-all-authorised-presentations_en.pdf
document_name: docetaxel-teva-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8769733
conversion_datetime: 2025-12-14 23:06:17.301007
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
Annex A

<!-- image -->

Medicinal product no longer authori

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength       | Pharmaceutical Form                               | Route of Administration   | Immediate Packaging                                 | Content (concentration)                | Pack size       |
|------------------|-------------------|----------------|---------------------------------------------------|---------------------------|-----------------------------------------------------|----------------------------------------|-----------------|
| EU/1/09/611/001  | Docetaxel TEVA    | 20 mg /0.72 ml | Concentrate and solvent for solution for infusion | Intravenous use           | concentrate: vial (glass); solvent: vial (glass) ml | concentrate: 0.72 ml; solvent: 1.28    | 1 vial + 1 vial |
| EU/1/09/611/002  | Docetaxel TEVA    | 80 mg /2.88 ml | Concentrate and solvent for solution for infusion | Intravenous use           | concentrate: vial (glass); solvent: vial (glass)    | concentrate: 2.88 ml; solvent: 5.12 ml | 1 vial + 1 vial |

<!-- image -->